PitchBook News - Tracking the SaaS tools for growth

Scoping out the VC defense-tech boom; investors revive confidence in healthcare staffing; mapping M&A's recovery
Read online | Don't want to receive these emails? Manage your subscription.
PitchBook
Log in
The Daily Pitch: VC
November 6, 2023
The Daily Pitch is powered by PitchBook’s industry-defining research and best-in-class data
Ads
In today's Daily Pitch, you'll find:
 
Today's Top Stories  
Tracking the SaaS tools for growth
Infrastructure SaaS, encompassing the tools powering digital transformation, has grown into a $400 billion-plus market that's projected to nearly double in size by 2027. With clients such as Microsoft, IBM and Salesforce, infrastructure SaaS companies are the backbone of industries like cloud computing, AI and data analytics.

That's why we're rolling out dedicated research coverage of the vertical with our Q3 2023 Launch Report: Infrastructure SaaS. Explore the players in M&A, the risks and potential rewards for fledgling startups, and the leading players in everything from DevOps to application infrastructure.
read the preview
 
Share: Email LinkedIn Twitter Facebook
Sizing up the VC boom in defense tech
(Glowimages/Getty Images)
Recent wars and rising tensions with China have highlighted the Pentagon's ongoing need to retool its arsenal with the latest technologies. VCs increasingly believe startups will play a meaningful role in these innovations.

US-based companies in the defense-tech sector have collected nearly $100 billion in VC funding since 2021, a figure that's about 40% higher than what was invested in the seven prior years combined.
read more
 
Share: Email LinkedIn Twitter Facebook
 
A message from the American Investment Council  
Fueling health care innovation
Private equity is playing an increasingly important role in life sciences. Over the past decade, PE firms have sponsored almost 1,000 companies in the life sciences ecosystem—including contract research organizations, staffing providers and drug ingredient manufacturers.

Today, however, PE firms are starting to finance the drugs themselves. In 2021, Bain Capital and NovaQuest Capital Management injected $125 million into Cerevel Therapeutics to help finance the entire Phase 3 trials of its promising therapy for Parkinson's disease.

In conjunction with PitchBook, the American Investment Council has released Improving Medical Technologies: Private equity's role in life sciences. PE's role as an innovative capital provider is much more extensive than many realize.

To download the report and learn more, click here.
Share: Email LinkedIn Twitter Facebook
 
Healthcare staffing PE deals persist in fallout of bankruptcies
(RealPeopleGroup/Getty Images)
Charging out-of-network prices for doctors within in-network hospitals has been banned for nearly two years. So perhaps it shouldn't be a surprise that the No Surprises Act has seriously pressured the business model of the physician staffing companies that relied on those out-of-network payments.

While some PE firms are losing billions as their clinical staffing companies go bankrupt, others are finding fresh opportunities in other types of contract-based staffing, like nursing and long-term care.
read more
 
Share: Email LinkedIn Twitter Facebook
M&A recovery gets pushed out to 2024
M&A deal value nearly hit a 10-year low in the third quarter, but market conditions are pointing to a recovery next year. Our Q3 2023 Global M&A Report, sponsored by Liberty GTS, breaks down trends shaping dealmaking and explores the signs for a revival.

Trillions of dollars in dry powder for PE sponsors and cash piles kept on hand by corporations are positioned for new deals. In addition, lower valuations may spur public strategic buyers to scoop up private targets.
read the report
 
Share: Email LinkedIn Twitter Facebook
Recommended Reads
Meta's free AI isn't cheap to use, companies say. [The Information]

Electric planes, once a fantasy, start to take to the skies. [The New York Times]

Visualizing the global wealth pyramid. [Visual Capitalist]
 
Ads
Since yesterday, the PitchBook Platform added:
1
VC valuations
44
People
25
Companies
See what our data software can do
 
The Daily Benchmark:
2019 Vintage Global Real Assets Funds
Median IRR
13.56%
Top Quartile IRR
20.16%
0.16x
Median DPI
Select top performers
Pacific Equity Partners Secure Assets Fund
Scout Energy Partners V
Ridgewood Energy Oil & Gas Fund IV
*IRR: net of fees
41 Funds in Benchmark »
Check out the latest version of PitchBook Benchmarks
 
VC Deals  
German insurtech startup WeFox raised $55 million at a $4.5 billion valuation from Deutsche Bank and UniCredit, CNBC reported.

Gynesonics, which develops treatments for uterine fibroids, raised $42.5 million led by investors including Bain Capital, Endeavour Vision and Kaiser Permanente Ventures.

Talus Renewables raised a $22 million Series A led by Material Impact and Xora Innovation for its green ammonia infrastructure system.

Superhog, a UK-based risk management platform for property managers, has raised £5.5 million in a round led by 6 Degrees Capital, Hambro Perks and Solano Partners.

Open-source coding platform developer Charm raised $6 million led by Gradient.

Vienna-based biotech startup HeartBeat.bio has closed a €4.5 million pre-Series A co-led by i&i Biotech Fund, Invest, AWS Grunderfonds and Tensor Ventures.

Smalt, a Berlin-based B2B solar installation services company, has secured a €4.1 million pre-seed investment led by La Famiglia.
 
Don't miss our upcoming webinar
Underwhelming stock performance thwarted the hope for a resurgence in IPOs this year, which was led by Instacart and Klaviyo's Q3 listings. An increasingly investor-friendly market is expected to further slow the pace of dealmaking, compress deal metrics and set an even higher bar for startups across the VC lifecycle. Our speakers will highlight findings from the Q3 2023 PitchBook-NVCA Venture Monitor, sponsored by Insperity, J.P. Morgan, Dentons, and Deloitte, and what investors should be aware of for 2024.
  • The liquidity crunch and shuttered IPO window have left startups across all VC stages with fewer options for receiving capital.

  • Dry powder figures appear strong, but without a consensus on whether the market has hit bottom, investors are more cautious than ever about deploying capital.

  • Portfolio markdowns, the denominator effect and interest rates have diminished LP interest in the VC asset class.
Register now to secure your spot.
Share: Email LinkedIn Twitter Facebook
 
PE Deals  
EQT has revived its efforts to acquire Global Switch in a deal that could value the Chinese data center company at around $6.5 billion, Bloomberg reported.

Cinven’s €2.2 billion bid for German medical diagnostic specialist Synlab has been met with a neutral response from the company's board, neither urging shareholders to accept nor decline the offer.

The Jordan Company is in exclusive talks to acquire Tidi Products, a Wisconsin-based medical equipment maker, from Roundtable Healthcare Partners for at least $900 million, Reuters reported.

TA Associates made a growth investment in KatRisk, a software company based in the Bay Area that models global catastrophes for flood and wind risk for insurance companies.
 
Exits & IPOs  
Cardinal Equity Partners and Oxford Financial are considering selling Indiana-based PolyWood, a maker of recycled plastic outdoor furniture, at a valuation of around $1 billion, Reuters reported.
 
Fundraising  
Norrsken22 has closed its debut African technology growth fund on $205 million.
 
Chart of the Day  
Source: PitchBook's Q3 2023 Global M&A Report
 
About PitchBook | Terms of use | Advertise with us | Contact
Follow us: in twtr fb

This email was sent to you via the PitchBook Platform.

Do you want to change your email address, get a different edition or unsubscribe? Manage your subscription here.

© 2023 PitchBook. Win what's next. All rights reserved.

Older messages

Ivys' not-so-elite returns

Sunday, November 5, 2023

Plus: Seed deals keep sprouting, the data that healthcare investors need, the future of open banking & more Read online | Don't want to receive these emails? Manage your subscription. Log in

Making sense of seed deal data

Saturday, November 4, 2023

Also: Mapping the global infrastructure SaaS ecosystem; Two webinars this week and new industry research for healthcare services and carbon tech... Read online | Don't want to receive these emails?

Fintech's opportunity in open banking

Friday, November 3, 2023

VC's David vs. Goliath moment in AI chips; M&A's recipe for a rebound; charting the course for IPOs; traditional finance embraces crypto tech Read online | Don't want to receive these

How LP returns are feeling the exit squeeze

Thursday, November 2, 2023

VC looks to UK for overseas deals; factory financing fuels carbon tech's record Q3; LBO equity contributions top 50% Read online | Don't want to receive these emails? Manage your subscription.

Climate-tech startups buck trends

Wednesday, November 1, 2023

How to raise a debut VC fund; Q&A: M12's new head on OpenAI, fresh focus; the heart of PE healthcare investing; 3 things a VC city needs Read online | Don't want to receive these emails?

You Might Also Like

Why The Greatest Sales Teams Kill It On Dec 31

Sunday, December 29, 2024

And the top SaaStr news of the week To view this email as a web page, click here This edition of the SaaStr Weekly is sponsored in part by Prismatic Why The Greatest Sales Teams Just Kill It On Dec 31.

Marketing Weekly #212

Sunday, December 29, 2024

Two Social Media Trends Are Changing How Men and Women Interact • How to Identify Your Ideal Customer Profile with the Medical Approach • 19 Ways To Monetize Your Substack — Even If You Think You Have

The Profile's 2024 Year in Review

Sunday, December 29, 2024

Here is 2024 through the eyes of The Profile. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Sunday Thinking ― 12.29.24

Sunday, December 29, 2024

"Remember, when a door closes. It's not rejection but divine protection." ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Why venture GPs keep going solo

Sunday, December 29, 2024

Plus: Context in benchmarking, a survey of tech VCs, & more Read online | Don't want to receive these emails? Manage your subscription. Log in The Weekend Pitch December 29, 2024 The Daily

Brain Food: Given Before Earned

Sunday, December 29, 2024

I learned this formula for success from Charlie Munger: ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Recruiting Brainfood - Issue 429

Sunday, December 29, 2024

The Odyssey of Talent Acquisition in 2025. Thank you being with me in 2024 - lets get ready to sail for 2025 ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏

Are you sure about your product/market fit?

Sunday, December 29, 2024

These deals are ending: Inro, Qolaba, MySEOAuditor, ContentRadar, and SEO Pilot - get them now to start off your 2025 right!! Get these lifetime deals now! (https://www.rockethub.com/) Today's hack

How to Describe Isolation

Saturday, December 28, 2024

How can we portray absence through the fullness of what surrounds it? ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

Explosive Growth with Programmatic SEO (But Beware! 😱)

Saturday, December 28, 2024

SEO Tip #66 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌